{"id":525,"date":"2014-10-31T07:55:45","date_gmt":"2014-10-31T06:55:45","guid":{"rendered":"https:\/\/realheart.se\/?p=525"},"modified":"2014-10-31T07:55:45","modified_gmt":"2014-10-31T06:55:45","slug":"real-heart-listningsemissionen-genomford","status":"publish","type":"post","link":"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/","title":{"rendered":"Real Heart: Listningsemissionen genomf\u00f6rd"},"content":{"rendered":"

Den 28 oktober 2014 avslutades teckningstiden i Scandinavian Real Heart AB:s (\u201dReal Heart\u201d) nyemission inf\u00f6r notering p\u00e5 AktieTorget. Nyemissionen tecknades till drygt 8,8 MSEK inklusive tecknings\u00e5tagare, vilket motsvarar en teckningsgrad om drygt 88 procent. Genom nyemissionen nyemitteras 1\u00a0920 625 aktier. Real Heart tillf\u00f6rs d\u00e4rmed drygt 8,8 MSEK (f\u00f6re emissionskostnader om cirka 0,8 MSEK) tillsammans med cirka 230 nya aktie\u00e4gare. Avr\u00e4kningsnotor \u00e4r ber\u00e4knade att skickas ut till tecknarna idag den 30 oktober 2014.<\/strong><\/p>\n

Vi vill h\u00e4lsa er hj\u00e4rtligt v\u00e4lkomna som del\u00e4gare i Scandinavian Real Heart AB och tacka f\u00f6r f\u00f6rtroendet. Genom nyemissionen och den efterf\u00f6ljande noteringen p\u00e5 AktieTorget har vi tagit klivet till n\u00e4sta fas i bolagets utveckling. Efter mer \u00e4n 14 \u00e5rs forskning har vi bland annat genomf\u00f6rt framg\u00e5ngsrika djurstudier i vilka flera viktiga parametrar verifierats. Vi avser nu genomf\u00f6ra mer omfattande tester med m\u00e5ls\u00e4ttningen att under 2017 kunna inleda studier i m\u00e4nniska. <\/em><\/p>\n

G\u00f6ran Hellers, styrelseordf\u00f6rande Scandinavian Real Heart AB
\nMedicine doktor och docent i kirurgi – Karolinska Institutet<\/p>\n

Notering p\u00e5 AktieTorget
\n<\/strong>F\u00f6rsta handelsdag p\u00e5 AktieTorget ber\u00e4knas bli den 26 november 2014. Aktiens handelsbeteckning kommer att vara HEART och ISIN-kod \u00e4r SE0006256798.<\/p>\n

Antal aktier och aktiekapital
\n<\/strong>N\u00e4r nyemissionen har registrerats hos Bolagsverket kommer det totala antalet aktier i Real Heart att uppg\u00e5 till 9\u00a0916 625 aktier och aktiekapitalet kommer att uppg\u00e5 till 991\u00a0662,50 SEK.<\/p>\n

Finansiell r\u00e5dgivare
\n<\/strong>Sedermera Fondkommission \u00e4r finansiell r\u00e5dgivare till bolaget i samband med nyemissionen och noteringen.<\/p>\n

F\u00f6r fr\u00e5gor med anledning av nyemissionen, v\u00e4nligen kontakta:
\n<\/strong>Sedermera Fondkommission
\n<\/em>Telefon: 0431-47 17 00
\n<\/em>E-post: <\/em>info@sedermera.se<\/em><\/a><\/p>\n

F\u00f6r ytterligare information om Scandinavian Real Heart AB, v\u00e4nligen kontakta:
\n<\/strong>Susanne Hedman, VD
\n<\/em>Telefon: 070- 44 44\u00a0521
\n<\/em>E-post: <\/em>susanne.hedman@realheart.se<\/em><\/a><\/p>\n

Scandinavian Real Heart AB
\n<\/strong>Kopparbergsv\u00e4gen 10, 722 13 V\u00e4ster\u00e5s
\n<\/em>Tel: 021 – 475 55 50
\n<\/em>www.realheart.se<\/em><\/p>\n

 <\/p>\n

\n

 <\/p>\n

Om Scandinavian Real Heart AB<\/em> \u2013 <\/em><\/strong>Endast cirka 5 000 hj\u00e4rttransplantationer sker \u00e5rligen i hela v\u00e4rlden och tillg\u00e5ngen p\u00e5 donerade hj\u00e4rtan \u00e4r mycket begr\u00e4nsad. Behovet \u00e4r stort och patienter med hj\u00e4rtsvikt avlider i v\u00e4ntan p\u00e5 ett nytt hj\u00e4rta. Scandinavian Real Heart AB utvecklar en hj\u00e4rtpump (TAH) som efterliknar kroppens naturliga cirkulation och som ska kunna anv\u00e4ndas som en \u00f6verg\u00e5ngsl\u00f6sning f\u00f6r patienter som v\u00e4ntar p\u00e5 en hj\u00e4rttransplantation. Framg\u00e5ngsrika studier har genomf\u00f6rts p\u00e5 s\u00f6vda djur och ytterligare djurstudier ska g\u00f6ras innan de f\u00f6rsta kliniska studierna i m\u00e4nniska kan genomf\u00f6ras. Hj\u00e4rtpumpens konstruktion och batterier ska ge patienten \u00f6kad r\u00f6rlighet och m\u00f6jlighet till h\u00f6gre livskvalit\u00e9.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Den 28 oktober 2014 avslutades teckningstiden i Scandinavian Real Heart AB:s (\u201dReal Heart\u201d) nyemission inf\u00f6r notering p\u00e5 AktieTorget. Nyemissionen tecknades till drygt 8,8 MSEK inklusive tecknings\u00e5tagare, vilket motsvarar en teckningsgrad om drygt 88 procent. Genom nyemissionen nyemitteras 1\u00a0920 625 aktier. Real Heart tillf\u00f6rs d\u00e4rmed drygt 8,8 MSEK (f\u00f6re emissionskostnader om cirka 0,8 MSEK) tillsammans med…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-525","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"acf":[],"aioseo_notices":[],"yoast_head":"\nReal Heart: Listningsemissionen genomf\u00f6rd - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Real Heart: Listningsemissionen genomf\u00f6rd - Realheart\" \/>\n<meta property=\"og:description\" content=\"Den 28 oktober 2014 avslutades teckningstiden i Scandinavian Real Heart AB:s (\u201dReal Heart\u201d) nyemission inf\u00f6r notering p\u00e5 AktieTorget. Nyemissionen tecknades till drygt 8,8 MSEK inklusive tecknings\u00e5tagare, vilket motsvarar en teckningsgrad om drygt 88 procent. Genom nyemissionen nyemitteras 1\u00a0920 625 aktier. Real Heart tillf\u00f6rs d\u00e4rmed drygt 8,8 MSEK (f\u00f6re emissionskostnader om cirka 0,8 MSEK) tillsammans med...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-31T06:55:45+00:00\" \/>\n<meta name=\"author\" content=\"jonashornblad\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"jonashornblad\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/real-heart-listningsemissionen-genomford\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/real-heart-listningsemissionen-genomford\\\/\"},\"author\":{\"name\":\"jonashornblad\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#\\\/schema\\\/person\\\/17244490023a4da8de490482e34e655f\"},\"headline\":\"Real Heart: Listningsemissionen genomf\u00f6rd\",\"datePublished\":\"2014-10-31T06:55:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/real-heart-listningsemissionen-genomford\\\/\"},\"wordCount\":427,\"articleSection\":[\"Nyheter\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/sv\\\/real-heart-listningsemissionen-genomford\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/sv\\\/real-heart-listningsemissionen-genomford\\\/\",\"name\":\"Real Heart: Listningsemissionen genomf\u00f6rd - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2014-10-31T06:55:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#\\\/schema\\\/person\\\/17244490023a4da8de490482e34e655f\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/sv\\\/real-heart-listningsemissionen-genomford\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#\\\/schema\\\/person\\\/17244490023a4da8de490482e34e655f\",\"name\":\"jonashornblad\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3ee7f5a06e6b0eafec1be1b77e11cd82ad17f0fa01336f132450da089f67b7d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3ee7f5a06e6b0eafec1be1b77e11cd82ad17f0fa01336f132450da089f67b7d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e3ee7f5a06e6b0eafec1be1b77e11cd82ad17f0fa01336f132450da089f67b7d?s=96&d=mm&r=g\",\"caption\":\"jonashornblad\"},\"url\":\"https:\\\/\\\/realheart.se\\\/sv\\\/author\\\/jonashornblad\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Real Heart: Listningsemissionen genomf\u00f6rd - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/","og_locale":"sv_SE","og_type":"article","og_title":"Real Heart: Listningsemissionen genomf\u00f6rd - Realheart","og_description":"Den 28 oktober 2014 avslutades teckningstiden i Scandinavian Real Heart AB:s (\u201dReal Heart\u201d) nyemission inf\u00f6r notering p\u00e5 AktieTorget. Nyemissionen tecknades till drygt 8,8 MSEK inklusive tecknings\u00e5tagare, vilket motsvarar en teckningsgrad om drygt 88 procent. Genom nyemissionen nyemitteras 1\u00a0920 625 aktier. Real Heart tillf\u00f6rs d\u00e4rmed drygt 8,8 MSEK (f\u00f6re emissionskostnader om cirka 0,8 MSEK) tillsammans med...","og_url":"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/","og_site_name":"Realheart","article_published_time":"2014-10-31T06:55:45+00:00","author":"jonashornblad","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"jonashornblad","Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/#article","isPartOf":{"@id":"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/"},"author":{"name":"jonashornblad","@id":"https:\/\/realheart.se\/#\/schema\/person\/17244490023a4da8de490482e34e655f"},"headline":"Real Heart: Listningsemissionen genomf\u00f6rd","datePublished":"2014-10-31T06:55:45+00:00","mainEntityOfPage":{"@id":"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/"},"wordCount":427,"articleSection":["Nyheter"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/","url":"https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/","name":"Real Heart: Listningsemissionen genomf\u00f6rd - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2014-10-31T06:55:45+00:00","author":{"@id":"https:\/\/realheart.se\/#\/schema\/person\/17244490023a4da8de490482e34e655f"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/sv\/real-heart-listningsemissionen-genomford\/"]}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Person","@id":"https:\/\/realheart.se\/#\/schema\/person\/17244490023a4da8de490482e34e655f","name":"jonashornblad","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/e3ee7f5a06e6b0eafec1be1b77e11cd82ad17f0fa01336f132450da089f67b7d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e3ee7f5a06e6b0eafec1be1b77e11cd82ad17f0fa01336f132450da089f67b7d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e3ee7f5a06e6b0eafec1be1b77e11cd82ad17f0fa01336f132450da089f67b7d?s=96&d=mm&r=g","caption":"jonashornblad"},"url":"https:\/\/realheart.se\/sv\/author\/jonashornblad\/"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/posts\/525","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/comments?post=525"}],"version-history":[{"count":0,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/posts\/525\/revisions"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/categories?post=525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/tags?post=525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}